Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of Actinic Keratosis on the Face in Solid Organ Transplant Recipients
Phase of Trial: Phase IV
Latest Information Update: 05 May 2017
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Adverse reactions
- 02 May 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.
- 25 Oct 2016 Status changed from not yet recruiting to recruiting.
- 17 Aug 2016 New trial record